Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia

Autor: Solaymani-Dodaran, Masoud ^{a, b, c}, Ghanei, Mostafa ^{d, ⁎}, Bagheri, Mehdi ^e, Qazvini, Ali ^f, Vahedi, Ensieh ^g, Hassan Saadat, Seyed ^h, Amin Setarehdan, Seyed ^{i, j}, Ansarifar, Akram ^k, Biganeh, Hossein ^l, Mohazzab, Arash ^{m, n}, Khalili, Davood ^o, Hosein Ghazale, Amir ^p, Reza Heidari, Mohammad ^q, Taheri, Ali ^r, Khoramdad, Maliheh ^s, Mahdi Asadi, Mohammad ^t, Nazemieh, Masoud ^u, Varshochi, Mojtaba ^v, Abbasian, Samaneh ^w, Bakhtiari, Ali ^x, Mosaed, Reza ^y, Hosseini-shokouh, Seyyed-Javad ^z, Shahrokhi, Masoume ^aa, Yassin, Zeynab ^ab, Ali Zohal, Mohammad ^ac, Qaraati, Maryam ^ad, Rastgoo, Nafiseh ^ae, Sami, Ramin ^af, Javad Eslami, Mohammad ^ag, Asghari, Akram ^ah, Namazi, Mansoor ^ai, Ziaie, Shadi ^aj, Jafari-Moghaddam, Raana ^ak, Kalantari, Saeid ^al, Memarian, Mohammad ^am, Khodadadi, Javad ^an, Hossein Afshari, Mohammad ^ao, Momen-Heravi, Mansooreh ^ap, Behzadseresht, Niusha ^aq, Reza Mobayen, Ahmad ^ar, Mozafari, Abolfazl ^as, Movasaghi, Fatemeh ^at, Haddadzadeh Shoushtari, Maryam ^au, Moazen, Javad ^av

Publikováno v: In International Immunopharmacology June 2021 95